John S. Lam

6.5k total citations
85 papers, 4.2k citations indexed

About

John S. Lam is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, John S. Lam has authored 85 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Pulmonary and Respiratory Medicine, 34 papers in Molecular Biology and 20 papers in Surgery. Recurrent topics in John S. Lam's work include Renal cell carcinoma treatment (44 papers), Renal and related cancers (27 papers) and Bladder and Urothelial Cancer Treatments (15 papers). John S. Lam is often cited by papers focused on Renal cell carcinoma treatment (44 papers), Renal and related cancers (27 papers) and Bladder and Urothelial Cancer Treatments (15 papers). John S. Lam collaborates with scholars based in United States, France and Canada. John S. Lam's co-authors include Arie S. Belldegrun, Robert A. Figlin, John T. Leppert, Oleg Shvarts, Allan J. Pantuck, Mantu Gupta, Alberto Breda, Steven A. Rosenberg, Mark E. Reeves and Richard E. Royal and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

John S. Lam

83 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John S. Lam United States 35 2.8k 1.9k 812 801 783 85 4.2k
Jean‐Jacques Patard France 43 5.5k 1.9× 4.1k 2.1× 1.8k 2.3× 1.3k 1.6× 1.5k 1.9× 152 7.2k
Lance C. Pagliaro United States 41 2.4k 0.8× 1.6k 0.8× 2.1k 2.6× 2.1k 2.6× 1.0k 1.3× 199 5.9k
Nevin Murray Canada 38 3.3k 1.1× 1.4k 0.7× 932 1.1× 3.3k 4.1× 421 0.5× 121 6.2k
Jean‐Jacques Patard France 33 2.9k 1.0× 2.2k 1.1× 938 1.2× 579 0.7× 1.0k 1.3× 47 3.6k
Oluwole Fadare United States 36 1.0k 0.4× 1.3k 0.6× 746 0.9× 953 1.2× 1.0k 1.3× 255 4.7k
Sandra Collette Belgium 28 3.4k 1.2× 1.3k 0.7× 2.6k 3.2× 2.4k 3.0× 651 0.8× 73 6.4k
Nicole Ishill United States 39 2.4k 0.8× 942 0.5× 1.0k 1.2× 808 1.0× 548 0.7× 76 4.4k
Michael Siebels Germany 22 3.4k 1.2× 2.7k 1.4× 626 0.8× 1.6k 2.0× 1.6k 2.0× 65 5.2k
Saul E. Rivkin United States 40 2.0k 0.7× 820 0.4× 971 1.2× 3.6k 4.5× 1.1k 1.4× 127 5.8k
D. Scott Ernst Canada 30 2.8k 1.0× 1.2k 0.6× 925 1.1× 1.8k 2.2× 767 1.0× 77 4.3k

Countries citing papers authored by John S. Lam

Since Specialization
Citations

This map shows the geographic impact of John S. Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Lam more than expected).

Fields of papers citing papers by John S. Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John S. Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Lam. The network helps show where John S. Lam may publish in the future.

Co-authorship network of co-authors of John S. Lam

This figure shows the co-authorship network connecting the top 25 collaborators of John S. Lam. A scholar is included among the top collaborators of John S. Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John S. Lam. John S. Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lam, John S., Tobias Klatte, Jean‐Jacques Patard, et al.. (2007). Prognostic Relevance of Tumour Size in T3a Renal Cell Carcinoma: A Multicentre Experience. European Urology. 52(1). 155–162. 67 indexed citations
2.
Karakiewicz, Pierre I., Quoc‐Dien Trinh, John S. Lam, et al.. (2007). Platelet Count and Preoperative Haemoglobin Do Not Significantly Increase the Performance of Established Predictors of Renal Cell Carcinoma-Specific Mortality. European Urology. 52(5). 1428–1437. 28 indexed citations
3.
Patard, Jean‐Jacques, Allan J. Pantuck, Maxime Crépel, et al.. (2007). Morbidity and Clinical Outcome of Nephron-Sparing Surgery in Relation to Tumour Size and Indication. European Urology. 52(1). 148–154. 147 indexed citations
4.
Shvarts, Oleg, Nicolette Janzen, John S. Lam, et al.. (2006). RENCA/carbonic anhydrase-IX: A murine model of a carbonic anhydrase-IX-expressing renal cell carcinoma. Urology. 68(5). 1132–1138. 11 indexed citations
5.
Shuch, Brian, John S. Lam, & Arie S. Belldegrun. (2006). Open partial nephrectomy for the treatment of renal cell carcinoma. Current Urology Reports. 7(1). 31–38. 18 indexed citations
6.
Lam, John S., David B. Seligson, Hong‐Jeng Yu, et al.. (2006). Flap endonuclease 1 is overexpressed in prostate cancer and is associated with a high Gleason score. British Journal of Urology. 98(2). 445–451. 88 indexed citations
7.
Lam, John S., Arie S. Belldegrun, & Robert A. Figlin. (2006). Adjuvant treatment for renal cell carcinoma. Expert Opinion on Pharmacotherapy. 7(6). 705–720. 14 indexed citations
8.
Leppert, John T., John S. Lam, & Arie S. Belldegrun. (2005). Predicting Response to Interleukin-2 Therapy Among Patients with Renal Cell Carcinoma. Journal of Immunotherapy. 28(5). 427–429. 1 indexed citations
9.
Lam, John S., et al.. (2005). Open surgical management of renal cell carcinoma in the era of minimally invasive kidney surgery. British Journal of Urology. 96(9). 1268–1274. 3 indexed citations
10.
Shvarts, Oleg, John S. Lam, Hyung L. Kim, & Arie S. Belldegrun. (2005). Staging of renal cell carcinoma: current concepts. British Journal of Urology. 95(s2). 8–13. 9 indexed citations
11.
Lam, John S., Oleg Shvarts, Jonathan Said, et al.. (2005). Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. Cancer. 103(12). 2517–2525. 123 indexed citations
12.
Lam, John S. & Mantu Gupta. (2004). Update on ureteral stents. Urology. 64(1). 9–15. 39 indexed citations
13.
Lam, John S., Oleg Shvarts, & Arie S. Belldegrun. (2004). Kidney cancer management in 2004: An update for the practicing general urologist. Current Urology Reports. 5(1). 1–3. 2 indexed citations
14.
Kim, Hyung L., John S. Lam, & Arie S. Belldegrun. (2004). The role of lymphadenectomy in renal cell carcinoma. Current Urology Reports. 5(1). 25–29. 2 indexed citations
15.
Lam, John S. & Mantu Gupta. (2004). Ureteroscopic management of upper tract transitional cell carcinoma. Urologic Clinics of North America. 31(1). 115–128. 43 indexed citations
16.
Lam, John S., Kimberly L. Cooper, & Steven A. Kaplan. (2004). Changing aspects in the evaluation and treatment of patients with benign prostatic hyperplasia. Medical Clinics of North America. 88(2). 281–308. 8 indexed citations
17.
Lam, John S., Nicholas A. Romas, & Franklin C. Lowe. (2003). Long-term treatment with finasteride in men with symptomatic benign prostatic hyperplasia: 10-year follow-up. Urology. 61(2). 354–358. 27 indexed citations
18.
Lam, John S., et al.. (2003). Endoscopic treatment of fibroepithelial polyps of the renal pelvis and ureter. Urology. 62(5). 810–813. 63 indexed citations
19.
20.
Lam, John S., et al.. (2001). Use of prostatic stents for the treatment of benign prostatic hyperplasia in high-risk patients. Current Urology Reports. 2(4). 277–284. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Jacques Patard Breakdown of academic impact, for papers by Lance C. Pagliaro Breakdown of academic impact, for papers by Nevin Murray Breakdown of academic impact, for papers by Jean‐Jacques Patard Breakdown of academic impact, for papers by Oluwole Fadare Breakdown of academic impact, for papers by Sandra Collette Breakdown of academic impact, for papers by Nicole Ishill Breakdown of academic impact, for papers by Michael Siebels Breakdown of academic impact, for papers by Saul E. Rivkin Breakdown of academic impact, for papers by D. Scott Ernst
Rankless by CCL
2026